Your browser doesn't support javascript.
loading
Hypoglycaemia symptom frequency, severity, burden, and utility among adults with type 1 diabetes and impaired awareness of hypoglycaemia: Baseline and 24-week findings from the HypoCOMPaSS study.
Søholm, Uffe; Holmes-Truscott, Elizabeth; Broadley, Melanie; Amiel, Stephanie A; Hendrieckx, Christel; Choudhary, Pratik; Pouwer, Frans; Shaw, James A M; Speight, Jane.
Afiliación
  • Søholm U; Medical & Science, Patient Focused Drug Development, Novo Nordisk A/S, Søborg, Denmark.
  • Holmes-Truscott E; Department of Psychology, University of Southern Denmark, Odense, Denmark.
  • Broadley M; Department of Diabetes, School of Cardiovascular Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Amiel SA; The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Victoria, Australia.
  • Hendrieckx C; School of Psychology, Institute for Health Transformations, Deakin University, Geelong, Victoria, Australia.
  • Choudhary P; Institute for Health Transformation, Deakin University, Geelong, Victoria, Australia.
  • Pouwer F; Department of Psychology, University of Southern Denmark, Odense, Denmark.
  • Shaw JAM; Department of Diabetes, School of Cardiovascular Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Speight J; The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Victoria, Australia.
Diabet Med ; 41(1): e15231, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37746767
ABSTRACT

AIMS:

To determine the frequency, severity, burden, and utility of hypoglycaemia symptoms among adults with type 1 diabetes (T1D) and impaired awareness of hypoglycaemia (IAH) at baseline and week 24 following the HypoCOMPaSS awareness restoration intervention.

METHODS:

Adults (N = 96) with T1D (duration 29 ± 12 years; 64% women) and IAH completed the Hypoglycaemia Burden Questionnaire (HypoB-Q), assessing experience of 20 pre-specified hypoglycaemia symptoms, at baseline and week 24.

RESULTS:

At baseline, 93 (97%) participants experienced at least one symptom (mean ± SD 10.6 ± 4.6 symptoms). The proportion recognising each specific symptom ranged from 15% to 83%. At 24 weeks, symptom severity and burden appear reduced, and utility increased.

CONCLUSIONS:

Adults with T1D and IAH experience a range of hypoglycaemia symptoms. Perceptions of symptom burden or utility are malleable. Although larger scale studies are needed to confirm, these findings suggest that changing the salience of the symptomatic response may be more important in recovering protection from hypoglycaemia through regained awareness than intensifying symptom frequency or severity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemia Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemia Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM